Statera Biopharma, Inc.
STAB
Revenue
670.47k
▼-98.35k▼-12.79%
3 Months ChangeAssets
12.75M
▼-793.21k▼-5.86%
3 Months ChangeLiabilities
22.92M
▲2.45M▲11.99%
3 Months ChangeFree Cash Flow
-3.77M
▼-1.17M▼-45.09%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-02-01
Form 8-K
ID: 0001437749-23-002260
2023-01-20
Form 8-K
ID: 0001437749-23-001440
2022-11-15
Form 8-K
ID: 0001437749-22-027404
2022-11-14
Form 10-Q
ID: 0001437749-22-027371
2022-11-07
Form 8-K
ID: 0001437749-22-026090
2022-10-28
Form 10-Q
ID: 0001437749-22-025006
2022-10-27
Form 8-K
ID: 0001437749-22-024960
2022-10-24
Form 8-K
ID: 0001437749-22-024547
2022-10-21
Form 10-Q
ID: 0001437749-22-024497
2022-10-17
Form 8-K
ID: 0001437749-22-024253